Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) vs Lunai Bioworks Inc. (LNAI)
A side-by-side comparison of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares and Lunai Bioworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$2.12HealthcareDelayed quote: Oct 6, 2026, 11:03 AM EDT
LNAI
Lunai Bioworks Inc.
$1.15HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
Total return — CUPR vs LNAI
growth of $100 · dividends reinvested · last 1yCUPR -68.3% (-68.3%/yr)LNAI -93.8% (-93.8%/yr)CUPR compounded faster over this window
Log scale — wide-divergence pair
CUPR LNAI
CUPR vs LNAI: by the numbers
- •CUPR is the larger company ($6M vs $5M market cap).
- •Both run net losses; CUPR's is the smaller (-9366.75% vs -612568.11% net margin).
Metrics side by side
Valuation
| Metric | CUPR | LNAI |
|---|---|---|
| P/S ratio | N/A | 248.97 |
| P/B ratio | 1.45 | N/A |
Profitability
| Metric | CUPR | LNAI |
|---|---|---|
| Gross margin | -1.29% | 0.00% |
| Operating margin | -9154.62% | 0.00% |
| Net margin | -9366.75% | -612568.11% |
| ROE | -92.44% | N/A |
| ROIC | -84.15% | N/A |
Go deeper
Dig into the metrics
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ROELunai Bioworks ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginLunai Bioworks operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthLunai Bioworks revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flowLunai Bioworks free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.